S. B. Kaye

Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial.

S. Kaye, N. Reed, R. Jones, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

D. Cruickshank, S. M. Crawford, S. Kaye, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long‐term follow‐up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart, K. Swenerton, I. Vergote, 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC).

M. Gore, K. Pennert, S. Kaye, 2012, Gynecologic oncology.

Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder.

S. Fosså, M. Parmar, S. Kaye, 1991, British journal of urology.

Novel therapeutic agents in ovarian cancer.

R. Agarwal, S. Kaye, M. Linch, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.